Sitagliptin Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on Metformin Immediate-Release Alone In a 24-week placebo-controlled trial of sitagliptin 100 mg administered once daily added to a twice daily metformin immediate-release regimen, there were no adverse reactions reported regardless of investigator assessment of causality in 5% of patients and more commonly than in patients given placebo
Common side effects include nausea, vomiting, diarrhoea, and abdominal pain, which may be more pronounced in patients with altered gastrointestinal anatomy
If there were a way to lower the amount of blood in the chamber after beating, it follows that blood pressure may be lowered
When To Start The beauty of Sofwave is that you do not need to wait until skin laxity becomes severe
And most people on GLP-1s are also obese or overweight, increasing the likelihood of reflux
Considering Long-Term Treatment Options As treatment continues beyond the early months, long-term planning becomes an important part of care see why medical supervision matters for GLP-1 therapy
.png)
